Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Discover which credit cards provide the best points redemption options. Make informed choices to maximize your rewards potential.
25,677 articlesA long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
A record-sized end-of-quarter options expiry is set to roll across Bitcoin and Ethereum, potentially stirring markets...
A two-day pension fund rebalance could move about $30 billion of U.S. stocks, posing near-term volatility but often a...
The equal-weight S&P 500 outperformed the cap-weighted index this week as investors rotate away from mega cap tech to...
MicroStrategy's crypto treasury, dubbed Strategy, remains substantially underwater as Saylor signals another bitcoin ...
BNY Mellon will now support Circle’s USDC on its Digital Asset Custody platform for institutional clients. In a histo...
Legislation on the CLARITY Act moves toward a pivotal Senate floor vote, even as law-enforcement groups push back on ...
Gold defies a recent selloff with a strong long-term bid. A leading commodities chief argues the setup remains intact...
Stryker and Intuitive Surgical reported divergent Q1 2026 results, underscoring two distinct medtech playbooks. Stryk...
A debt-free couple earning $100,000 a year reports zero savings, prompting a rare on-air moment of doubt from Dave Ra...
A public disagreement rumor meets real-world finance. Discover how the idea that there’s no feud can translate into p...